Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

KRYS holding history

Krystal Biotech, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRYS overviewAll 13F holders of KRYSFull Q2 2026 holdings

Shares (Q2 2026)
148,316
Value
$55.1M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of KRYS by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026148,316$55.1M<0.1%+4,791+3.3%AddedHolders
Q1 2026143,525$37.1M<0.1%−16,070−10.1%ReducedHolders
Q4 2025159,595$39.3M<0.1%+29,422+22.6%AddedHolders
Q3 2025130,173$23.0M<0.1%+32,933+33.9%AddedHolders
Q2 202597,240$13.4M<0.1%+16,121+19.9%AddedHolders
Q1 202581,119$14.6M<0.1%−19,012−19.0%ReducedHolders
Q4 2024100,131$15.7M<0.1%+63,802+175.6%AddedHolders
Q3 202436,329$6.61M<0.1%+7,773+27.2%AddedHolders
Q2 202428,556$5.24M<0.1%−22,472−44.0%ReducedHolders
Q1 202451,028$9.08M<0.1%+20,268+65.9%AddedHolders
Q4 202330,760$3.82M<0.1%+30,760NewHolders
Q3 20230$00.0%−11,217−100.0%Sold outHolders
Q2 202311,217$1.32M<0.1%−16,911−60.1%ReducedHolders
Q1 202328,128$2.25M<0.1%−14,495−34.0%ReducedHolders
Q4 202242,623$3.38M<0.1%+42,459+25,889.6%AddedHolders
Q3 2022164$11.0K<0.1%−15,670−99.0%ReducedHolders
Q2 202215,834$1.04M<0.1%−42,236−72.7%ReducedHolders
Q1 202258,070$3.86M<0.1%+56,237+3,068.0%AddedHolders
Q4 20211,833$128.0K<0.1%−21,490−92.1%ReducedHolders
Q3 202123,323$1.22M<0.1%+21,315+1,061.5%AddedHolders
Q2 20212,008$137.0K<0.1%−35,379−94.6%ReducedHolders
Q1 202137,387$2.88M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.